Immunoglobulin solutions for patients with primary immunodeficiency. Comments on Burnouf et al.'s ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’-Reference-Cited by-同舟云学术

Immunoglobulin solutions for patients with primary immunodeficiency. Comments on Burnouf et al.'s ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’

Published:2024-06-18 Issue:9 Volume:119 Page:1021-1022
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sanguinis

Author:

Pergent Martine¹,Prevot Johan¹,Solis Leire¹,Farrugia Albert²³^ORCID

Affiliation:

1. The International Patient Organisation for Primary Immunodeficiencies (IPOPI) Brussels Belgium

2. Network of Experts, IPOPI Brussels Belgium

3. Faculty of Medicine and Health Sciences The University of Western Australia (M509) Perth Australia

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.13696

Reference6 articles.

1. Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries

2. Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries

3. European Medicines Agency (EMA).Virus validation studies: the design contribution and interpretation of studies validating inactivation removal viruses – scientific guideline.2018. Available from:https://www.ema.europa.eu/en/virus‐validation‐studies‐design‐contribution‐interpretation‐studies‐validating‐inactivation‐removal. Last accessed 27 Aug 2023.

4. Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance

5. Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–2015